Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-16

FDA Approved: URSODIOL — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved Amneal's Ursodiol generic under an Original Application (ANDA 211301), enabling its marketing as a generic therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • URSODIOL (ursodiol)

Snippet

ORIG AP for URSODIOL (URSODIOL)